Stock listing

NASDAQ:IMDX Insight Molecular Diagnostics Inc. Stock

Home listing (NASDAQ) of Insight Molecular Diagnostics Inc.

Follow Insight Molecular Diagnostics Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:IMDX

$3.01 USD -0.05 (-1.6%)

Close on Oct 16, 2026

Insight Molecular Diagnostics Inc. logo
Ticker
NASDAQ:IMDX
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Insight Molecular Diagnostics (NASDAQ:IMDX) Q2 2026 Earnings Call

    Mon, Aug 10, 2026 · 5:00 PM ET

    Watch Transcript

  • Insight Molecular Diagnostics (NASDAQ:IMDX) Q1 2026 Earnings Call

    Wed, May 13, 2026 · 5:00 PM ET

    Watch Transcript

  • Insight Molecular Diagnostics (NASDAQ:IMDX) Q4 2025 Earnings Call

    Thu, Mar 26, 2026 · 5:00 PM ET

    Watch Transcript

Latest news

iMDx Welcomes New Diagnostics Sales Leader to Prepare for Planned GraftAssureDx Launch

Oct 14, 2026

iMDx to Participate in Virtual U.S. Bancorp I BTIG Kidney Health Forum with KOL Discussion and Investor Meetings

Oct 12, 2026

iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference

Sep 2, 2026

IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx

Aug 10, 2026

iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference

Aug 4, 2026

iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication

Jul 23, 2026

IMDx Chief Science Officer Ekkehard Schuetz Publishes 200th Research Paper

Jun 29, 2026

iMDx and the American Society of Transplant Surgeons Announce Recipients of the ASTS-iMDx Health Economics Research Grant

Jun 22, 2026

Favorable Head-to-Head Data on iMDx’s GraftAssure with Competing NGS Assay Published in Clinical Chemistry

Jun 16, 2026

IMDX GraftAssure Assay Sets New Standard in Screening Kidney Transplant Patients Per American Journal of Transplantation

Jun 11, 2026

All Insight Molecular Diagnostics Inc. news

Decks

Insight Molecular Diagnostics Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
28 in the last 12 months · 41 in all · newest Oct 14, 2026 · oldest 2025
Calls
21 calls with a replay · 21 with a transcript · latest Aug 10, 2026
Decks
28 decks · latest August 2026

Where Insight Molecular Diagnostics Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:IMDX · Home listing · This pageNASDAQUnited StatesUSD
LSE:0KCCLSEUnited KingdomUSD
BOATS:IMDXBOATSUnited StatesUSD
Frankfurt:7OC0FrankfurtGermanyEUR
gettex:7OC0gettexGermanyEUR
Munich:7OC0MunichGermanyEUR
Tradegate:7OC0TradegateGermanyEUR

Log in to ask 6ix AI your own questions about Insight Molecular Diagnostics Inc.